{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T21:19:15Z","timestamp":1767734355279,"version":"3.48.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,6]]},"DOI":"10.7759\/cureus.100945","type":"journal-article","created":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T21:15:34Z","timestamp":1767734134000},"source":"Crossref","is-referenced-by-count":0,"title":["Psychotic Risk Associated With Cannabinoid Use: A Case Report of Ekbom-Like Delusional Infestation"],"prefix":"10.7759","author":[{"given":"Miguel","family":"Pao Trigo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joana","family":"Cavaco Rogrigues","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Luz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joaquim","family":"S\u00e1 Couto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Mota Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbw003","article-title":"Meta-analysis of the association between the level of cannabis use and risk of psychosis","volume":"42","author":"Marconi A","year":"2016","unstructured":"Marconi A, Di Forti M, Lewis CM, Murray RM, Vassos E. Meta-analysis of the association between the level of cannabis use and risk of psychosis. Schizophr Bull. 2016, 42:1262-9. 10.1093\/schbul\/sbw003","journal-title":"Schizophr Bull"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(19)30048-3","article-title":"The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study","volume":"6","author":"Di Forti M","year":"2019","unstructured":"Di Forti M, Quattrone D, Freeman TP, et al.. The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study. Lancet Psychiatry. 2019, 6:427-36. 10.1016\/S2215-0366(19)30048-3","journal-title":"Lancet Psychiatry"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2023.115626","article-title":"A systematic evidence map of the association between cannabis use and psychosis-related outcomes across the psychosis continuum: an umbrella review of systematic reviews and meta-analyses","volume":"331","author":"Groening JM","year":"2024","unstructured":"Groening JM, Denton E, Parvaiz R, Brunet DL, Von Daniken A, Shi Y, Bhattacharyya S. A systematic evidence map of the association between cannabis use and psychosis-related outcomes across the psychosis continuum: an umbrella review of systematic reviews and meta-analyses. Psychiatry Res. 2024, 331:115626. 10.1016\/j.psychres.2023.115626","journal-title":"Psychiatry Res"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2025.2539","article-title":"Cannabis use among individuals with psychosis after state-level commercial cannabis legalization","author":"Hyatt AS","year":"2025","unstructured":"Hyatt AS, Flores MW, Johnson J, Bien-Aime D, Evins AE, \u00d6ng\u00fcr D, Cook BL. Cannabis use among individuals with psychosis after state-level commercial cannabis legalization. JAMA Psychiatry. 2025, e252539. 10.1001\/jamapsychiatry.2025.2539","journal-title":"JAMA Psychiatry"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2018.03.013","article-title":"The psychiatric consequences of cannabinoids","volume":"40","author":"De Aquino JP","year":"2018","unstructured":"De Aquino JP, Sherif M, Radhakrishnan R, Cahill JD, Ranganathan M, D'Souza DC. The psychiatric consequences of cannabinoids. Clin Ther. 2018, 40:1448-56. 10.1016\/j.clinthera.2018.03.013","journal-title":"Clin Ther"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2017.06.018","article-title":"Cannabis-associated psychosis: neural substrate and clinical impact","volume":"124","author":"Murray RM","year":"2017","unstructured":"Murray RM, Englund A, Abi-Dargham A, et al.. Cannabis-associated psychosis: neural substrate and clinical impact. Neuropharmacology. 2017, 124:89-104. 10.1016\/j.neuropharm.2017.06.018","journal-title":"Neuropharmacology"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/nature20153","article-title":"The effects of \u0394(9)-tetrahydrocannabinol on the dopamine system","volume":"539","author":"Bloomfield MA","year":"2016","unstructured":"Bloomfield MA, Ashok AH, Volkow ND, Howes OD. The effects of \u0394(9)-tetrahydrocannabinol on the dopamine system. Nature. 2016, 539:369-77. 10.1038\/nature20153","journal-title":"Nature"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2016.01.011","article-title":"Human laboratory studies on cannabinoids and psychosis","volume":"79","author":"Sherif M","year":"2016","unstructured":"Sherif M, Radhakrishnan R, D'Souza DC, Ranganathan M. Human laboratory studies on cannabinoids and psychosis. Biol Psychiatry. 2016, 79:526-38. 10.1016\/j.biopsych.2016.01.011","journal-title":"Biol Psychiatry"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2008.138","article-title":"Delta 9-tetrahydrocannabinol induces dopamine release in the human striatum","volume":"34","author":"Bossong MG","year":"2009","unstructured":"Bossong MG, van Berckel BN, Boellaard R, et al.. Delta 9-tetrahydrocannabinol induces dopamine release in the human striatum. Neuropsychopharmacology. 2009, 34:759-66. 10.1038\/npp.2008.138","journal-title":"Neuropsychopharmacology"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(16)30188-2","article-title":"Effects of continuation, frequency, and type of cannabis use on relapse in the first 2 years after onset of psychosis: an observational study","volume":"3","author":"Schoeler T","year":"2016","unstructured":"Schoeler T, Petros N, Di Forti M, et al.. Effects of continuation, frequency, and type of cannabis use on relapse in the first 2 years after onset of psychosis: an observational study. Lancet Psychiatry. 2016, 3:947-53. 10.1016\/S2215-0366(16)30188-2","journal-title":"Lancet Psychiatry"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbz102","article-title":"Transition of substance-induced, brief, and atypical psychoses to schizophrenia: a systematic review and meta-analysis","volume":"46","author":"Murrie B","year":"2020","unstructured":"Murrie B, Lappin J, Large M, Sara G. Transition of substance-induced, brief, and atypical psychoses to schizophrenia: a systematic review and meta-analysis. Schizophr Bull. 2020, 46:505-16. 10.1093\/schbul\/sbz102","journal-title":"Schizophr Bull"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1177\/07067437241290187","article-title":"Cannabis use cessation and the risk of psychotic disorders: a case-control analysis from the first episode case-control EU-GEI WP2 study [Article in French]","volume":"70","author":"Bond BW","year":"2025","unstructured":"Bond BW, Duric B, Spinazzola E, et al.. Cannabis use cessation and the risk of psychotic disorders: a case-control analysis from the first episode case-control EU-GEI WP2 study [Article in French]. Can J Psychiatry. 2025, 70:182-93. 10.1177\/07067437241290187","journal-title":"Can J Psychiatry"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2024.111359","article-title":"Association between cannabis potency and mental health in adolescence","volume":"261","author":"Hines LA","year":"2024","unstructured":"Hines LA, Cannings-John R, Hawkins J, et al.. Association between cannabis potency and mental health in adolescence. Drug Alcohol Depend. 2024, 261:111359. 10.1016\/j.drugalcdep.2024.111359","journal-title":"Drug Alcohol Depend"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106258","article-title":"Cannabis induced psychosis: a systematic review on the role of genetic polymorphisms","volume":"181","author":"Carvalho C","year":"2022","unstructured":"Carvalho C, Vieira-Coelho MA. Cannabis induced psychosis: a systematic review on the role of genetic polymorphisms. Pharmacol Res. 2022, 181:106258. 10.1016\/j.phrs.2022.106258","journal-title":"Pharmacol Res"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(22)00161-4","article-title":"Association of cannabis potency with mental ill health and addiction: a systematic review","volume":"9","author":"Petrilli K","year":"2022","unstructured":"Petrilli K, Ofori S, Hines L, Taylor G, Adams S, Freeman TP. Association of cannabis potency with mental ill health and addiction: a systematic review. Lancet Psychiatry. 2022, 9:736-50. 10.1016\/S2215-0366(22)00161-4","journal-title":"Lancet Psychiatry"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.106.029660","article-title":"Antipsychotic treatment of primary delusional parasitosis: systematic review","volume":"191","author":"Lepping P","year":"2007","unstructured":"Lepping P, Russell I, Freudenmann RW. Antipsychotic treatment of primary delusional parasitosis: systematic review. Br J Psychiatry. 2007, 191:198-205. 10.1192\/bjp.bp.106.029660","journal-title":"Br J Psychiatry"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1055\/s-2008-1062697","article-title":"Successful treatment of delusional disorder of the somatic type or \"delusional parasitosis\" with olanzapine","volume":"41","author":"Bosmans A","year":"2008","unstructured":"Bosmans A, Verbanck P. Successful treatment of delusional disorder of the somatic type or \"delusional parasitosis\" with olanzapine. Pharmacopsychiatry. 2008, 41:121-2. 10.1055\/s-2008-1062697","journal-title":"Pharmacopsychiatry"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00018-09","article-title":"Delusional infestation","volume":"22","author":"Freudenmann RW","year":"2009","unstructured":"Freudenmann RW, Lepping P. Delusional infestation. Clin Microbiol Rev. 2009, 22:690-732. 10.1128\/CMR.00018-09","journal-title":"Clin Microbiol Rev"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajp.2012.09.008","article-title":"Delusional infestation: a clinical profile","volume":"6","author":"Bhatia MS","year":"2013","unstructured":"Bhatia MS, Jhanjee A, Srivastava S. Delusional infestation: a clinical profile. Asian J Psychiatr. 2013, 6:124-7. 10.1016\/j.ajp.2012.09.008","journal-title":"Asian J Psychiatr"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/446743-psychotic-risk-associated-with-cannabinoid-use-a-case-report-of-ekbom-like-delusional-infestation","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T21:15:35Z","timestamp":1767734135000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/446743-psychotic-risk-associated-with-cannabinoid-use-a-case-report-of-ekbom-like-delusional-infestation"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,6]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.100945","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1,6]]}}}